Beruflich Dokumente
Kultur Dokumente
The XXXIII Biennial Meeting of the International Society of Eye Research takes place this year from
September 9-13th in Belfast, Northern Ireland, UK. Dr Jenni J. Hakkarainen – Acting COO of
Experimentica Ltd. will present an oral presentation on a metalloporphyrin superoxide dismutase
mimetic and the dry-eye disease. Dr Simon Kaja – CSO of Experimentica Ltd. will chair a session
and present on cellular mechanisms of reactive astrocytosis and opportunities for glioprotection.
Kuopio, Finland, September 08, 2018 --(PR.com)-- Experimentica Ltd. announces its participation in the
scientific sessions at the biennial meeting of the International Society of Eye Research. The event takes
place September 9th - 13th at the Belfast Waterfront Meeting Centre 2 Lanyon Place, Belfast, BT1 3WH.
Through its participation in this year's ISER meeting Experimentica Ltd. is proud to be able to showcase
its scientific know-how as well as its world-class researchers through its presentations and abstracts. It is
our hope that attendees will feel free to make contact with them in order to discuss their scientific
research as well as the Experimentica Ltd. product offering.
Experimentica Ltd. extends a warm welcome to all attendees at this years meeting.
Ocular Pharmacology, Therapeutics and Drug Discovery, Meeting Room 3A 13.09.2018 13:00-15:00.
About Experimentica Ltd.: Experimentica Ltd. is a global contract research organization (CRO) that
specializes in preclinical models of ophthalmology and neurology. The world class scientists and
technicians apply a comprehensive set of skills on various in vitro, ex vivo and in vivo modelling
platforms. With proprietal laboratories in Kuopio, Finland, and representation globally, Experimentica
Ltd. delivers the highest quality science in ophthalmology and neurological models.
Page 1/2
PR.com Press Release Distribution Terms of Use
Contact Information:
Experimentica Ltd
Dr. Simon Kaja
+1(844)3934393
Contact via Email
www.experimentica.com
Page 2/2
PR.com Press Release Distribution Terms of Use